Lead Opinion
Following a decision of the District Court granting summary judgment to GlaxoSmithKline LLC ("GSK"), the losing parties, two health benefit plans, appealed from that final order.
We conclude that the District Court failed to apply the proper legal standard for the common law right of access, which requires as a starting point the application of a presumption of public access.
See
Bank of Am. Nat'l Tr. & Sav. Ass'n v. Hotel Rittenhouse Assocs.
,
I.
A.
GSK manufactures, markets, and sells Avandia, a drug indicated to treat Type II diabetes.
B.
On May 21, 2010, in the midst of heightened regulatory and public scrutiny of Avandia, United Food and Commercial Workers Local 1776 and Participating Employers Health and Welfare Fund ("UFCW") filed suit against GSK in the United States District Court for the Eastern District of Pennsylvania. UFCW alleged violations of the Racketeer Influenced and Corrupt Organizations Act ("RICO"), as well as various state consumer protection laws. J.B. Hunt Transport Services, Inc. ("J.B. Hunt") filed a complaint containing similar claims on June 20, 2011. Both UFCW and J.B. Hunt (collectively referred to as "the plans") filed suit on behalf of a proposed class of United States health benefit providers that had purchased Avandia. These third-party payor cases became part of a multi-district litigation ("MDL"), which also included
consumer and personal injury cases.
In November 2010, GSK moved to dismiss the plans' complaints, arguing that the plans lacked standing to bring RICO claims. In October 2013, the District Court denied that motion; it later certified its decision for interlocutory appeal. We granted permission to appeal and, in October 2015, affirmed the District Court's denial of GSK's motion to dismiss.
Avandia I
,
Less than a year later, GSK moved for summary judgment as to the plans' consumer protection claims on federal preemption grounds. GSK also contended that the plans' RICO claims should be dismissed for failing to identify a distinct RICO enterprise. In the course of briefing GSK's motion for summary judgment, the parties filed documents under seal pursuant to PTO 10. At that time, neither party raised any issue as to the confidentiality of the sealed exhibits. On December 7, 2017, the District Court granted GSK's motion for summary judgment.
After the plans appealed the District Court's summary judgment ruling, GSK indicated that it wanted to maintain the confidentiality of certain sealed documents that had been filed in connection with the summary judgment motion. GSK therefore moved in the District Court to keep some of the summary judgment records under seal. On May 31, 2018, the District Court granted in part and denied in part GSK's motion (the "May Sealing Order"). App. 2459. The Court unsealed its own summary judgment opinion but maintained the confidentiality of the remainder of the documents.
A few weeks later, GSK again moved to maintain under seal additional summary judgment records. The District Court granted in part and denied in part the second sealing motion on July 24, 2018 (the "July Sealing Order"). Id. at 2460-61. The Court directed GSK to file a redacted statement of undisputed material facts but otherwise maintained the seal. Id.
The plans timely appealed the May Sealing Order (No. 18-2259) and the July Sealing Order (No. 18-2656).
II.
We apply three distinct standards when considering various challenges to the confidentiality of documents. We apply the factors articulated in
Pansy v. Borough of Stroudsburg
,
A.
Federal Rule of Civil Procedure 26(c) permits the District Court to enter a
protective order to shield a party "from annoyance, embarrassment, oppression, or undue burden or expense." Fed. R. Civ. P. 26(c)(1). A protective order is "intended to offer litigants a measure of privacy, while balancing against this privacy interest the public's right to obtain information concerning judicial proceedings."
Pansy
,
The proponent of the protective order shoulders "[t]he burden of justifying the confidentiality of each and every document sought to be" sealed.
We have set forth various factors-"which are neither mandatory nor exhaustive"-that courts may consider when determining whether good cause exists and, by extension, whether a protective order should issue:
1. whether disclosure will violate any privacy interests;
2. whether the information is being sought for a legitimate purpose or for an improper purpose;
3. whether disclosure of the information will cause a party embarrassment;6
4. whether confidentiality is being sought over information important to public health and safety;
5. whether the sharing of information among litigants will promote fairness and efficiency;
6. whether a party benefitting from the order of confidentiality is a public entity or official; and
7. whether the case involves issues important to the public.
Glenmede Tr. Co. v. Thompson
,
B.
Analytically distinct from the District Court's ability to protect discovery materials under Rule 26(c), the common law presumes that the public has a right of access to judicial materials. In both criminal and civil cases, a common law right of access attaches "to judicial proceedings and records."
In re Cendant Corp.
,
The right of access includes the right to attend court proceedings and to "inspect and copy public records and documents, including judicial records and documents."
In re Cendant Corp.
,
"[T]here is a presumptive right of public access to pretrial motions of a nondiscovery nature, whether preliminary or dispositive, and the material filed in connection therewith."
Yet the common law right of access is "not absolute."
Bank of Am.
,
To overcome that strong presumption, the District Court must articulate "the compelling, countervailing interests to be protected," make "specific findings on the record concerning the effects of disclosure," and "provide[ ] an opportunity for interested third parties to
be heard."
In re Cendant Corp.
,
C.
Finally, the public and the press have a First Amendment right of access to civil trials.
Publicker Indus.
,
It remains an open question in this Circuit whether the First Amendment right of access applies to records of summary judgment proceedings. We use a two-prong test to assess whether the right of access attaches: (1) the experience prong asks "whether the place and process have historically been open to the press"; and (2) the logic prong evaluates "whether public access plays a significant positive role in the functioning of the particular process in question."
N. Jersey Media Grp. Inc. v. United States
,
"The First Amendment right of access requires a much higher showing than the common law right [of] access before a judicial proceeding can be sealed."
In re Cendant Corp.
,
The party seeking closure or sealing in the face of the First Amendment right of access "bears the burden of showing that the material is the kind of information that courts will protect and that there is good cause for the order to issue."
Procedurally, the District Court "must both articulate the countervailing interest it seeks to protect and make findings specific enough that a reviewing court can determine whether the closure order was properly entered."
III.
A.
Although the plans invoked the common law right of access, the District Court assessed GSK's motions for continued confidentiality by applying the Rule 26 standard governing protective orders. In its one-page May Sealing Order, the District Court granted in part and denied in part GSK's motion to preserve the confidentiality of the summary judgment records. App. 2459. The Court denied GSK's motion with respect to the summary judgment opinion, which the Court unsealed without redaction. The Court granted the motion as to all other documents. In doing so, the District Court neither cited the applicable legal standard nor discussed the specific documents at issue. The Court later explained that its reasoning in the July Sealing Order applied equally to the May Sealing Order.
In its July Sealing Order, the Court again granted in part and denied in part GSK's second motion to maintain confidentiality.
Id.
at 2460-61. The District Court ordered GSK to file a redacted version of its statement of undisputed material facts. The Court otherwise granted the motion for continued confidentiality. In a footnote, the District Court quoted the
Pansy
factors, explaining that this Court has instructed district courts to weigh the factors when determining whether good cause exists to justify a protective order under Rule 26. The District Court mentioned the common law right of access, acknowledging that the moving party must show that disclosure "will work a clearly defined and serious injury to it."
Id.
at 2460 n.1 (internal quotation marks omitted) (quoting
Miller
,
The District Court's analysis, contained in the same footnote, went as follows:
In this case, [GSK] has articulated a specific and substantial harm from making public its confidential communications to the FDA, including harm to its competitive standing, to its commercial reputation, and to its relationships with physicians and patients. [GSK] is thus seeking to preserve the confidentiality of these documents for a legitimate purpose. Given the potential harm to [GSK] by disclosing these communications with the FDA, and the fact that there are no substantial countervailing interests other than the public's broad right to review a judicial proceeding, the Court will grant [GSK]'s Motion with respect to the identified documents containing communications with the FDA. The Court will deny the motion, however, with respect to preserving the confidentiality of the entirety of the submitted statement of undisputed facts. [GSK] may redact the confidential communications with the FDA contained in the statement of undisputed facts, but [GSK] ha[s] not demonstrated why the full submission should be kept confidential.
B.
It is undisputed that each of the challenged documents are "judicial records" subject to the common law right of access because the parties filed the documents on the District Court's public docket in support of, or in opposition to, GSK's motion for summary judgment.
See
Westinghouse Elec. Corp.
,
The District Court, relying on
LEAP Systems
, seems to have considered the
Pansy
factors as the only applicable legal standard, equating the Rule 26 analysis with the common law right of access analysis. But
LEAP Systems
does not support such an approach. There, after years of contentious litigation and failed mediation attempts, the parties entered into a settlement agreement with the district court's assistance.
LEAP Sys., Inc.
,
Reviewing for abuse of discretion, we agreed.
Weighing the public's interest in disclosure, we considered the district court's reliance on some of the
Pansy
factors: whether confidentiality was being sought over information important to public health and safety, whether the sharing of information among litigants would promote fairness and efficiency, whether the party benefitting from the order of confidentiality was a public entity or official, and whether the case involved issues important to the public.
See
Nowhere in
LEAP Systems
did we hold that the
Pansy
factors supplanted our longstanding common law right of access standard. Rather, we determined that the district court did not abuse its discretion by weighing
some
of these factors when considering the public's interest in disclosure. In short, while the
Pansy
factors may provide useful guidance for courts conducting the balancing required by the common law test, the
Pansy
factors do not displace the common law right of access standard. The difference is not merely semantic-the
Pansy
factors are not sufficiently robust for assessing the public's right to access judicial records. Unlike the Rule 26 standard, the common law right of access begins with a thumb on the scale in favor of openness-the strong presumption of public access.
Compare
Pansy
,
Moreover, some of the
Pansy
factors are incompatible with our case law on the common law right of access. One of the
Pansy
factors assesses "whether disclosure of the information will cause a party embarrassment."
Glenmede Tr.Co.
,
Pansy
also considers "whether the information is being sought for a legitimate
purpose or for an improper purpose."
Glenmede Tr. Co.
,
We conclude that by conflating the Pansy factors with the common law right of access standard, the District Court committed an error of law.
C.
Having explained that the Pansy factors are not a substitute for the common law right of access standard-which begins with the presumption of access-we turn to whether the District Court nonetheless applied the strong presumption required by the common law right of access. We conclude that it did not, and we must therefore remand.
As noted above, the District Court did acknowledge the common law right of access. It failed, however, to acknowledge the presumption of public accessibility. It reasoned that continued sealing is proper given that "there are no substantial countervailing interests
other than
the public's broad right to review a judicial proceeding." App. 2461 n.1 (emphasis added). This analysis gave insufficient weight to the public's interest in openness. Consideration of the public's right of access must be the starting point, not just one of multiple factors. The scale is tipped at the outset in favor of access. And the right of access is not a mere formality-it "promotes public confidence in the judicial system"; "diminishes possibilities for injustice, incompetence, perjury, and fraud"; and "provide[s] the public with a more complete understanding of the judicial system and a better perception of its fairness."
Littlejohn
,
The District Court also erred by not conducting a document-by-document review, instead analyzing sixty-five disputed documents in a single paragraph contained in a footnote. This collective evaluation of the harm allegedly suffered by GSK falls short of the exacting analysis our precedent requires.
See
Leucadia, Inc.
,
Again, the strong presumption of openness inherent in the common law right of access "disallows the routine and perfunctory closing of judicial records."
In re Cendant Corp.
,
D.
In remanding for the District Court to apply the appropriate standard in the first instance, we offer a few observations about the evidence GSK submitted in support of sealing. To support its requests for continued confidentiality, GSK provided an eight-year-old declaration-the Armand Declaration-which actually supported sealing a different set of documents.
Perhaps realizing the deficiencies of the Armand Declaration, GSK submitted a second declaration in its reply brief in support of its second motion to seal. This declaration, the Walker Declaration, contains broad, vague, and conclusory allegations of harm that are, standing alone, insufficient to overcome the presumption of public access.
Finally, it seems that GSK is relying on allegations of reputational injury to support continued confidentiality. For example, the District Court discussed the "harm to [GSK's] competitive standing, to its commercial reputation, and to its relationships with physicians and patients." App. 2461 n.1. To be sure, courts may permissibly seal judicial records "where they are sources of business information that might harm a litigant's competitive standing."
Westinghouse Elec. Corp.
,
We will vacate the May and July Sealing Orders and remand this matter to permit the District Court to conduct a detailed review of the challenged documents by applying the proper standard for accessibility under the common law.
See
Leucadia, Inc.
,
E.
The plans and amici have asked us to go further. According to them, the First Amendment right of public access applies to summary judgment records. But, whereas we have extended the common law right of access to summary judgment records, we have yet to do so under the First Amendment right of public access.
We have repeatedly declined to tackle the contours of the First Amendment right of public access when the common law right has been sufficient to permit access.
See, e.g.
,
In re Cendant Corp.
,
Although the constitutional issue is an interesting one, we again decline to define the parameters of the First Amendment right in a case where the common law right affords sufficient protection. Indeed, at oral argument counsel for the plans agreed that we need not reach the First Amendment issue if unsealing is required under the common law right of access.
See
Tr. of Oral Arg. 3:24-4:13, (Mar. 6, 2019);
see also
In re Cendant Corp.
,
If on remand the District Court concludes that any of the sealed documents merits continued confidentiality under the common law right of access, then the Court should also consider the parties' arguments regarding the First Amendment right of public access.
IV.
Instead of applying the common law right of access, the District Court assessed GSK's motions for continued confidentiality using the rule applicable to protective orders. Because the District Court should conduct the required document-by-document review under the correct legal standard in the first instance, we will vacate and remand the May Sealing Order as well as the July Sealing Order.
We are separately considering that appeal, No. 18-1010, which challenges the District Court's summary judgment ruling.
As previously mentioned, the plans have separately appealed the District Court's grant of summary judgment. We therefore recount only the limited facts and procedural history necessary to decide the sealing issues.
The word "indicated" is a term of art within the pharmaceutical industry meaning to use a drug or device for an approved purpose.
Cf.
Buckman Co. v. Plaintiffs' Legal Comm.
,
District Judge Rufe has presided over the Avandia MDL with commendable care and efficiency since October 2007.
As we have previously stated, "in cases involving large-scale discovery, the court may construct a broad umbrella protective order upon a threshold showing by the movant of good cause."
Pansy v. Borough of Stroudsburg
,
Although "preventing embarrassment may be a factor satisfying the 'good cause' standard," the proponent of a protective order "must demonstrate that the embarrassment will be particularly serious."
The Court also "retains the power to modify or lift confidentiality orders that it has entered."
We exercise jurisdiction under
To that end, the parties have briefed the sealing of certain appendices on appeal. Because our assessment of the appellate motions to seal overlaps with the District Court's analysis on remand, we will defer such an assessment until after the District Court has had the opportunity to consider GSK's motions under the correct standard. All disputed documents filed in this appeal will continue to be held provisionally under seal.
Even under the more lenient standard for a protective order, the District Court's analysis would not be sufficient. We have repeatedly counseled that the party seeking confidentiality must bear the burden of justifying sealing.
Leucadia, Inc. v. Applied Extrusion Techs., Inc.
,
To be clear, we do not require a district court to provide lengthy, detailed discussion of each individual document. Yet it must be clear from the record that the district court engaged in a particularized, deliberate assessment of the standard as it applies to each disputed document. We are unable to discern such exacting review from the single paragraph provided in the July Sealing Order, in which a multitude of documents spanning several years were divided into broad categories.
The declaration of former Executive Product Director for Avandia, Timothy Armand, was originally submitted in support of a 2010 challenge to the confidentiality of documents. Although GSK argues that "the same types of documents" covered by the Armand Declaration are at issue here, Br. of Appellee 40, we have no way to verify that assertion. See Br. of Appellants 25 n.93 (explaining that the Armand Declaration references documents by Bates numbers, which are then listed on a separate appendix not provided to the plans or the Court).
The plans urge us to disregard entirely the Walker Declaration because it was inappropriately submitted on reply. The plans argue that they raised the deficiencies of the Armand Declaration in their opposition to the first sealing motion but that GSK failed to submit the Walker Declaration, which was designed to correct those deficiencies, until its reply to the second sealing motion. Because we will remand for the District Court's consideration of GSK's first and second sealing motions, we leave for that Court to decide whether to consider the Walker Declaration.
GSK has not claimed that any of the sealed documents contain trade secrets-a noted exception to the presumption of public access. Confidential business information "is not entitled to the same level of protection from disclosure as trade secret information."
Republic of the Philippines v. Westinghouse Elec. Corp.
,
Two of our sister circuits have held that the First Amendment right of public access applies to summary judgment documents.
See
Lugosch v. Pyramid Co. of Onondaga
,
Because we do not reach the First Amendment issue, we decline to address GSK's arguments that the plans lack Article III standing to assert First Amendment claims, or that they have partially waived these claims.
Concurrence in Part
I join the majority opinion in its entirety, with the exception of Part III.E. In that portion of the opinion, the majority, as a matter of constitutional avoidance, "decline[s] to define the parameters of the First Amendment" because, in the majority's view, "the common law right affords sufficient protection" in this case. I depart from the majority because, in my view, the Court should address the First Amendment issues raised by the plans. I write separately to express my view that the doctrine of constitutional avoidance is inapplicable to the facts of this case and that the First Amendment right of public access extends to documents submitted in connection with motions for summary judgment.
I.
The Court could reach the First Amendment issues in this case without running afoul of the doctrine of constitutional avoidance. The Supreme Court indeed has counseled that federal courts "should not decide federal constitutional questions where a dispositive nonconstitutional ground is available," but, in my view, the majority has not given proper weight to the key modifier in that clause-"dispositive."
Hagans v. Lavine
,
The majority appears to acknowledge that our holding is not a final determination on the merits of this matter insofar as the majority recognizes that this litigation will continue, and the Court subsequently will be required to address the First Amendment issues, if the District Court finds on remand that certain of the sealed documents merit continued confidentiality under the more lenient common law right of access standard. In such an event, as one of our sister circuits has recognized, "[e]ach passing day" between the District Court's decision to maintain the confidentiality of a sealed document and this Court's eventual adjudication of the First Amendment issues "may constitute a separate and cognizable infringement of the First Amendment."
Lugosch v. Pyramid Co. of Onondaga
,
The cases cited by the majority-in which this Court utilized only the common law right of access standard, rather than the more rigorous First Amendment standard-do not persuade me otherwise. In all but one of the cited cases, this Court definitively held that the documents in question should be unsealed pursuant to the common law right of access, leaving no room for doubt as to whether it might later become necessary to apply the more rigorous First Amendment standard to unseal such documents.
See
In re Cendant Corp.
,
For the reasons stated above, I respectfully disagree with the majority's decision not to address the First Amendment issues raised by the plans in this case, and I would join our two sister circuits that took up this constitutional issue when it was presented to them in a similar posture.
See
Lugosch
,
II.
Having determined that the Court should address the First Amendment issues raised by the plans,
See
Lugosch
,
This Court previously has held that "the First Amendment, independent of the common law, protects the public's right of access to the records of civil proceedings"-specifically, civil trials.
Westinghouse
,
Given the increasing frequency with which district courts utilize summary judgment to resolve federal civil litigation, in my view, the First Amendment public right of access that this Court extended to "records of civil proceedings,"
Westinghouse
,
For the reasons stated above, the Court should hold that the First Amendment right of public access extends to documents submitted in connection with motions for summary judgment. In light of the contemporary trend toward disposing of civil cases through summary judgment, the public should have a qualified right to view the documents submitted by parties in connection with motions for summary judgment. As the Supreme Court has stated, "[p]eople in an open society do not demand infallibility from their institutions, but it is difficult for them to accept what they are prohibited from observing."
Richmond Newspapers, Inc. v. Virginia
,
III.
In sum, I respectfully disagree with the majority's application of the doctrine of constitutional avoidance, which should only be invoked by a federal court when the court can decide a case on a "
dispositive
nonconstitutional ground."
Hagans
,
As an ancillary matter, GSK's argument regarding the plans' lack of "standing" is something of a misnomer. This is not a case in which a named plaintiff failed to demonstrate Article III standing to bring the substantive claim in a complaint on behalf of a putative class; it is undisputed that the District Court has jurisdiction over the underlying matter. Rather, this appeal arises out of the District Court's grant of two motions filed by GSK in the underlying matter to preserve the confidentiality of the documents submitted in connection with its motion for summary judgment. The plans opposed both of these motions and, either explicitly or through citation to case law, raised (and, consequently, preserved) arguments with respect to the First Amendment right of public access. The plans-as the named plaintiffs in a putative class action-are required to "fairly and adequately protect the interests of the class," Fed. R. Civ. P. 23(a)(4), in order "to ensure that absentees' interests are fully pursued,"
Georgine v. Amchem Prods., Inc.
,
